Cellnex


Pause in external growth

14/11/22 -"The Q3 numbers were in line with expectations. The management is now focusing more on organic growth and seems committed to deleveraging. A temporary halt to external growth is a positive point in ..."

Pages
61
Language
English
Published on
14/11/22
You may also be interested by these reports :
26/04/24
A good start to the year for Proximus with Q1 Domestic revenue up by 4.5% but, above all, a global EBITDA up by 5% yoy and definitely better than ...

24/04/24
The Stoxx600 takes a breather and Telecoms step in. The no-growth profile of Telcos becomes a safety profile justified by highish yields (4.75% at ...

24/04/24
The Q1 figures were in line with the Group’s 2025 objective of a steady 2/3% yoy EBITDA growth. This should allow organic cash-flow to grow by >10% ...

24/04/24
In 2024, KPN’s EBITDA margin should return to its 2022 record level of c.47.5% while its service revenues should grow by 4% yoy. Capex will remain ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO